Steven Cohen’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-67,938
Closed -$127K – 4353
2026
Q2
$127K Sell
67,938
-15,105
-18% -$39.9K ﹤0.01% 3658
2026
Q1
$322K Buy
83,043
+22,210
+37% +$54.6K ﹤0.01% 3337
2025
Q4
$119K Buy
+60,833
New +$100K ﹤0.01% 3720
2021
Q3
– Sell
-64,866
Closed -$655K – 1172
2021
Q2
$655K Sell
64,866
-66,610
-51% -$721K ﹤0.01% 847
2021
Q1
$1.81M Buy
+131,476
New +$1.82M 0.01% 741

Other funds holding NAUT

Steven Cohen's NAUT Position: Q3 2026 in Review

Steven Cohen sold out of Nautilus Biotechnolgy (NAUT) in Q3 2026, closing a stake of 67,938 shares — an estimated $127K sold.

Steven Cohen first reported a position in NAUT in Q1 2021 and held it in 5 quarters. The position peaked at $1.81M in Q1 2021. 88 funds tracked by Wall St. Rank hold NAUT as of Q3 2026.

  • Steven Cohen reported no remaining Nautilus Biotechnolgy position as of Q3 2026 after selling out during the quarter.
  • Steven Cohen sold 67,938 Nautilus Biotechnolgy shares in Q3 2026, an estimated $127K.
  • Steven Cohen first reported a position in Nautilus Biotechnolgy in Q1 2021 and held it in 5 quarters.
  • Steven Cohen's Nautilus Biotechnolgy position peaked at $1.81M in Q1 2021.
  • 88 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.